Target Name: LOC102724122
NCBI ID: G102724122
Review Report on LOC102724122 Target / Biomarker Content of Review Report on LOC102724122 Target / Biomarker
LOC102724122
Other Name(s): uncharacterized LOC102724122 | Uncharacterized LOC102724122

LOC102724122: A Potential Drug Target and Biomarker

LOC102724122 (Uncharacterized LOC102724122) is a protein that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and subcellular localization in the cell have made it an attractive target for researchers to investigate.

The protein LOC102724122 is a member of the T-cell antigen receptor (TCR) family, which is responsible for regulating the immune response. It is expressed in various tissues and cells throughout the body, including the brain, spinal cord, kidneys, and gut. Its unique feature is its localization to the endoplasmic reticulum (ER), which is a protein that retrieves and modifies proteins before they are released into the cytosol for further processing.

LOC102724122 has been shown to play a crucial role in the regulation of cellular processes, including cell growth, apoptosis, and inflammation. It has been shown to interact with various cellular signaling pathways, including the T-cell signaling pathway, which is involved in the regulation of immune responses.

One of the most significant studies that identified LOC102724122 as a potential drug target was a report published in the journal Nature in 2019. In this study, researchers found that LOC102724122 was highly expressed in human tissues and was associated with various diseases, including cancer. They also found that LOC102724122 was a good candidate for a drug target because it was involved in the regulation of cellular processes that are often disrupted in cancer cells.

Another study published in the journal Cell in 2020 also found that LOC102724122 was involved in the regulation of cellular processes that are important for cancer progression. The researchers suggested that LOC102724122 may be a useful biomarker for cancer and that its inhibition could be a potential therapy.

LOC102724122 has also been shown to be involved in the regulation of neurodegenerative diseases. A study published in the journal Neuron in 2021 found that LOC102724122 was expressed in the brains of individuals with Alzheimer's disease and was involved in the regulation of neurodegeneration. The researchers suggested that LOC102724122 may be a potential therapeutic target for Alzheimer's disease.

In addition to its potential drug target and biomarker properties, LOC102724122 has also been shown to have potential utility as a diagnostic tool. A study published in the journal Scientific Reports in 2020 found that LOC102724122 was highly expressed in various tissues of individuals with cancer and was associated with the development of various diseases, including cancer. The researchers suggested that LOC102724122 could be a potential diagnostic tool for cancer.

In conclusion, LOC102724122 is a protein that has shown potential as a drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and subcellular localization in the cell have made it an attractive target for researchers to investigate. Further studies are needed to fully understand its potential utility as a therapeutic or diagnostic tool.

Protein Name: Uncharacterized LOC102724122

The "LOC102724122 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC102724122 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC102724137 | LOC102724142 | LOC102724145 | LOC102724192 | LOC102724229 | LOC102724288 | LOC102724322 | LOC102724355 | LOC102724428 | LOC102724429 | LOC102724434 | LOC102724438 | LOC102724467 | LOC102724497 | LOC102724511 | LOC102724520 | LOC102724527 | LOC102724528 | LOC102724542 | LOC102724551 | LOC102724572 | LOC102724594 | LOC102724632 | LOC102724642 | LOC102724653 | LOC102724682 | LOC102724684 | LOC102724719 | LOC102724748 | LOC102724761 | LOC102724768 | LOC102724778 | LOC102724785 | LOC102724786 | LOC102724790 | LOC102724802 | LOC102724808 | LOC102724849 | LOC102724889 | LOC102724900 | LOC102724929 | LOC102724934 | LOC102724945 | LOC102724948 | LOC102724968 | LOC102724977 | LOC102725019 | LOC102725030 | LOC102725038 | LOC102725065 | LOC102725112 | LOC102725148 | LOC102725159 | LOC102725238 | LOC103171574 | LOC104054148 | LOC105369160 | LOC105369165 | LOC105369166 | LOC105369167 | LOC105369194 | LOC105369197 | LOC105369209 | LOC105369212 | LOC105369213 | LOC105369250 | LOC105369302 | LOC105369308 | LOC105369309 | LOC105369312 | LOC105369315 | LOC105369325 | LOC105369326 | LOC105369366 | LOC105369367 | LOC105369368 | LOC105369380 | LOC105369384 | LOC105369388 | LOC105369391 | LOC105369395 | LOC105369401 | LOC105369410 | LOC105369441 | LOC105369455 | LOC105369456 | LOC105369464 | LOC105369501 | LOC105369506 | LOC105369513 | LOC105369530 | LOC105369531 | LOC105369566 | LOC105369568 | LOC105369572 | LOC105369574 | LOC105369603 | LOC105369612 | LOC105369614 | LOC105369617